IDEXX Laboratories, Inc.
DE ˙ XTRA ˙ US45168D1046
€ 490,30 ↑19.90 (4.23%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:IX1 / IDEXX Laboratories, Inc.
InstitutionBokf, Na
Latest Disclosed Ownership2,969 shares
Latest Disclosed Value $ 1,668,251
Bokf, Na reports 25.27% increase in ownership of IX1 / IDEXX Laboratories, Inc.

On May 8, 2026 - Bokf, Na filed a 13F-HR form disclosing ownership of 2,969 shares of IDEXX Laboratories, Inc. (DE:IX1) valued at $1,448,872 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 2,370 shares of IDEXX Laboratories, Inc.. This represents a change in shares of 25.27% during the quarter. The current value of the position is $1,455,701 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F IDEXX LABORATORIES common 45168D104 2,969 599 25.27 1,668 4.05 0.0196
2026-02-03 2025-12-31 13F IDEXX LABORATORIES common 45168D104 2,370 -334 -12.35 1,603 -7.18 0.0245
2025-11-13 2025-09-30 13F IDEXX LABORATORIES common 45168D104 2,704 -103 -3.67 1,728 14.75 0.0260
2025-08-12 2025-06-30 13F IDEXX LABORATORIES common 45168D104 2,807 22 0.79 1,506 28.74 0.0244
2025-05-13 2025-03-31 13F IDEXX LABORATORIES common 45168D104 2,785 -461 -14.20 1,170 -13.79 0.0207
2025-02-14 2024-12-31 13F IDEXX LABORATORIES common 45168D104 3,246 -29 -0.89 1,357 -14.34 0.0229
2024-11-14 2024-09-30 13F IDEXX LABORATORIES common 45168D104 3,275 -150 -4.38 1,584 -5.10 0.0281
2024-08-08 2024-06-30 13F IDEXX LABS COM 45168D104 3,425 -134 -3.77 1,669 -11.93 0.0300
2024-05-15 2024-03-31 13F IDEXX LABS COM 45168D104 3,559 53 1.51 1,895 -2.67 0.0345
2024-02-14 2023-12-31 13F IDEXX LABS COM 45168D104 3,506 -70 -1.96 1,946 36.27 0.0381
2023-11-14 2023-09-30 13F IDEXX LABS COM 45168D104 3,576 -2,042 -36.35 1,429 -49.38 0.0315
2023-08-21 2023-06-30 13F IDEXX LABS COM 45168D104 5,618 10 0.18 2,822 0.61 0.0575
2023-05-11 2023-03-31 13F IDEXX LABS COM 45168D104 5,608 -2,589 -31.58 2,804 -16.15 0.0587
2023-02-13 2022-12-31 13F IDEXX LABS COM 45168D104 8,197 -1,510 -15.56 3,344 5.76 0.0617
2022-11-14 2022-09-30 13F IDEXX LABS COM 45168D104 9,707 -1,458 -13.06 3,162 -19.23 0.0640
2022-08-11 2022-06-30 13F IDEXX LABS COM 45168D104 11,165 94 0.85 3,915 -35.35 0.0751
2022-05-13 2022-03-31 13F IDEXX LABS COM 45168D104 11,071 -2,296 -17.18 6,056 -31.19 0.0998
2022-03-11 2021-12-31 13F IDEXX LABS COM 45168D104 13,367 978 7.89 8,801 14.24 0.1362
2021-11-10 2021-09-30 13F IDEXX LABS COM 45168D104 12,389 -240 -1.90 7,704 24.66 0.1325
2021-04-21 2021-03-31 13F IDEXX LABS COM 45168D104 12,629 -2,248 -15.11 6,180 -16.89 0.1124
2021-02-12 2020-12-31 13F IDEXX LABS COM 45168D104 14,877 -242 -1.60 7,436 25.10 0.1419
2020-10-30 2020-09-30 13F IDEXX LABS COM 45168D104 15,119 3,978 35.71 5,944 61.61 0.1306
2020-08-12 2020-06-30 13F IDEXX LABS COM 45168D104 11,141 -185 -1.63 3,678 34.09 0.0865
2020-05-13 2020-03-31 13F IDEXX LABS COM 45168D104 11,326 5,619 98.46 2,743 84.09 0.0790
2020-02-12 2019-12-31 13F IDEXX LABS COM 45168D104 5,707 -4,903 -46.21 1,490 -48.37 0.0337
2019-11-13 2019-09-30 13F IDEXX LABS COM 45168D104 10,610 8,594 426.29 2,886 419.06 0.0695
2019-08-14 2019-06-30 13F IDEXX LABS COM 45168D104 2,016 31 1.56 556 25.23 0.0134
2019-05-15 2019-03-31 13F IDEXX LABS COM 45168D104 1,985 100 5.31 444 26.50 0.0106
2019-02-13 2018-12-31 13F IDEXX LABS COM 45168D104 1,885 -214 -10.20 351 -33.02 0.0100
2018-11-13 2018-09-30 13F IDEXX LABS COM 45168D104 2,099 -57 -2.64 524 11.49 0.0132
2018-08-13 2018-06-30 13F IDEXX LABS COM 45168D104 2,156 50 2.37 470 16.63 0.0126
2018-05-14 2018-03-31 13F IDEXX LABS COM 45168D104 2,106 -2,531 -54.58 403 -44.41 0.0114
2018-02-14 2017-12-31 13F IDEXX LABS COM 45168D104 4,637 -182 -3.78 725 -3.20 0.0200
2017-11-14 2017-09-30 13F IDEXX LABS COM 45168D104 4,819 781 19.34 749 15.05 0.0217
2017-08-14 2017-06-30 13F IDEXX LABS COM 45168D104 4,038 -297 -6.85 651 -2.84 0.0205
2017-05-15 2017-03-31 13F IDEXX LABS COM 45168D104 4,335 -49 -1.12 670 30.35 0.0209
2017-02-14 2016-12-31 13F IDEXX LABS COM 45168D104 4,384 4,384 514 0.0169
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.